Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0JW9 stock hub

LON/0JW9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0JW9is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.6M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0JW9

In the news

Latest news · LON/0JW9

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-76.4

P25 -54.2P50 2.1P75 13.7

ROIC-18.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0JW9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	4
Employees Change	-24%
Employees Change Percent	-85.71
Enterprise value	$26.1M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US55279B3015
Last refreshed	2026-05-10
Market cap	$32.6M
Price	$1.2
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	lon/0JW9
Website	https://www.litestrategy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-90.6%
EV Earnings	-0.89x
P/B ratio	0.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-1.6M
Net Income	$-29.5M
Net Income Growth Years	0%
Profit Per Employee	$-7.4M
ROA	-19
Roa5y	-15.47
ROCE	-19.93
ROE	-76.38
Roe5y	-51.4
ROIC	-18.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.71%
Cagr3y	-37.35%
Cagr5y	-52.78%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$61.6M
Cash	$6.5M
Current Assets	$8M
Current Liabilities	$797,330
Equity	$60.8M
Liabilities	$807,641
Long Term Assets	$53.6M
Long Term Liabilities	$10,311
Net Cash	$6.5M
Net Cash By Market Cap	$19.99
Net Cash Growth	-63.11%
Net Debt Equity	$-0.11
Tangible Book Value	$60.8M
Tangible Book Value Per Share	$1.66
WACC	4.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.04
Net Working Capital	$792,781
Quick ratio	8.06
Working Capital	$7.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-200.82%
Dividend per share	$0
Last Dividend	$1.41

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.68%
200-day SMA	2.34
3Y total return	-75.42%
50-day SMA	1.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.65%
All Time High	90.8
All Time High Change	-98.68%
All Time High Date	2021-02-08
All Time Low	0.97
All Time Low Change	23.95%
All Time Low Date	2026-02-06
ATR	0.04
Beta	0.1
Ch YTD	-12.09
High	1.21
High52	11.26
High52 Date	2025-07-18
High52ch	-89.34%
Low	1.16
Low52	0.97
Low52 Date	2026-02-06
Low52ch	23.95%
Ma50ch	3.63%
Price vs 200-day SMA	-48.81%
RSI	54.7
RSI Monthly	36.7
RSI Weekly	37.96
Sharpe ratio	-0.62x
Sortino ratio	-0.89
Total Return	-200.82%
Tr YTD	-12.09
Tr1m	4.35%
Tr1w	5.26%
Tr3m	9.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-12.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,507,368%
Shares Insiders	11.21%
Shares Institutions	21.55%
Shares Qo Q	26.79%
Shares Yo Y	200.82%
Short Ratio	0.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,189.75x
Bv Per Share	1.66
Ch1m	4.35
Ch1w	5.26
Ch1y	-38.68
Ch3m	9.09
Ch3y	-80.98
Ch5y	-98.18
Ch6m	-44.44
Change	1.69%
Change From Open	3.45
Close	1.18
Days Gap	-1.69
Depreciation Amortization	134,966.6
Dollar Volume	502.8
Earnings Date	2026-05-19
EBIT	$-12.1M
EBITDA	$-12M
EPS	$-1.47
F Score	1
Financing CF	71,784,945
Fiscal Year End	June
Founded	2,000
Investing CF	-73,877,233
Is Primary Listing	0
Last Earnings Date	2026-02-10
Last Report Date	2025-12-31
Last Split Date	2023-04-17
Last Split Type	Reverse
Ma150	1.68
Ma150ch	-28.53%
Ma20	1.17
Ma20ch	3%
Net CF	-11,130,883
Next Earnings Date	2026-05-19
Open	1.16
Position In Range	81.82
Price Date	2026-05-08
Ptbv Ratio	0.54
Relative Volume	0.35x
Share Based Comp	454,716
Tr6m	-44.44%
Volume	419

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0JW9 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0JW9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0JW9?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.6%

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0JW9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.7

Neutral momentum band

Price vs 200-day MA

-48.8%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

-0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0JW9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JW9 stock rating?

lon/0JW9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JW9 analysis?

The full report lives at /stocks/lon/0JW9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JW9?

The latest report frames lon/0JW9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JW9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.